What does Dr. Le Clef Diagnostic Pathology do?

Dr. Le Clef Diagnostic Pathology is a specialist medical practice in Antwerpen. Private Limited, started on 10 July 2020, 1 establishment.

What is the address of Dr. Le Clef Diagnostic Pathology?

The registered office of Dr. Le Clef Diagnostic Pathology is located at Sanderusstraat 62, 2018 Antwerpen.

Is Dr. Le Clef Diagnostic Pathology still active?

Yes. According to the CBE (5 October 2026) Dr. Le Clef Diagnostic Pathology is active, legal situation “Normale toestand”, started on 10 July 2020.

Is Dr. Le Clef Diagnostic Pathology registered on Peppol?

Yes, Dr. Le Clef Diagnostic Pathology is registered on the Peppol network with ID 0208:0750547792.

What is the enterprise number of Dr. Le Clef Diagnostic Pathology?

The enterprise number of Dr. Le Clef Diagnostic Pathology is BE0750547792.

When was Dr. Le Clef Diagnostic Pathology founded?

Dr. Le Clef Diagnostic Pathology was founded on 10 July 2020.

Who are the directors of Dr. Le Clef Diagnostic Pathology?

According to the 2025 annual accounts, the directors of Dr. Le Clef Diagnostic Pathology are: Quentin Le Clef.

Is Dr. Le Clef Diagnostic Pathology a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 July 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Le Clef Diagnostic Pathology make in 2025?

Dr. Le Clef Diagnostic Pathology posted a profit after taxes of € 257,092 in financial year 2025.

What is the revenue of Dr. Le Clef Diagnostic Pathology?

As a small company, Dr. Le Clef Diagnostic Pathology is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 345,208.

Dr. Le Clef Diagnostic Pathology (Private Limited)

Dossier Dr. Le Clef Diagnostic Pathology, printed on 5 October 2026 from databakkes.be/en/0750547792/dr-le-clef-diagnostic-pathology. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Le Clef Diagnostic Pathology from Antwerpen, company number BE0750547792, closed financial year 2025 with a result of € 257,092 after tax. For that financial year Dr. Le Clef Diagnostic Pathology recorded a gross margin of € 345,208 and equity of € 312,938. Compared with financial year 2024, the result moved from € 239,112 to € 257,092. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.

What it is worth Growing

€ 312,938

▲ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 257,092

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 220,218

▲ 91% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 200,000 paid out

78 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 30,339

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,774

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 803

▼ 77% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 357,831 Gross margin 2022: € 357,831 First fiscal year in the series	€ 298,497 Gross margin 2023: € 298,497 ▼ 17% vs 2022 (€ 357,831) Unfavourable step	€ 317,617 Gross margin 2024: € 317,617 ▲ 6% vs 2023 (€ 298,497) Favourable step	€ 345,208 Gross margin 2025: € 345,208 ▲ 9% vs 2024 (€ 317,617) Favourable step	▲ 9%
Profit after taxes	€ 267,746 Profit after taxes 2022: € 267,746 First fiscal year in the series	€ 225,367 Profit after taxes 2023: € 225,367 ▼ 16% vs 2022 (€ 267,746) Unfavourable step	€ 239,112 Profit after taxes 2024: € 239,112 ▲ 6% vs 2023 (€ 225,367) Favourable step	€ 257,092 Profit after taxes 2025: € 257,092 ▲ 8% vs 2024 (€ 239,112) Favourable step	▲ 8%
Equity	€ 601,366 Equity 2022: € 601,366 First fiscal year in the series	€ 236,733 Equity 2023: € 236,733 ▼ 61% vs 2022 (€ 601,366) Unfavourable step	€ 255,846 Equity 2024: € 255,846 ▲ 8% vs 2023 (€ 236,733) Favourable step	€ 312,938 Equity 2025: € 312,938 ▲ 22% vs 2024 (€ 255,846) Favourable step	▲ 22%
Total debts	€ 157,224 Total debts 2022: € 157,224 First fiscal year in the series	€ 84,888 Total debts 2023: € 84,888 ▼ 46% vs 2022 (€ 157,224) Favourable step	€ 5,400 Total debts 2024: € 5,400 ▼ 94% vs 2023 (€ 84,888) Favourable step	€ 2,576 Total debts 2025: € 2,576 ▼ 52% vs 2024 (€ 5,400) Favourable step	▼ 52%
Cash	€ 718,026 Cash 2022: € 718,026 First fiscal year in the series	€ 232,137 Cash 2023: € 232,137 ▼ 68% vs 2022 (€ 718,026) Unfavourable step	€ 115,067 Cash 2024: € 115,067 ▼ 50% vs 2023 (€ 232,137) Unfavourable step	€ 220,218 Cash 2025: € 220,218 ▲ 91% vs 2024 (€ 115,067) Favourable step	▲ 91%
Retained profit	€ 596,366 Retained profit 2022: € 596,366 First fiscal year in the series	€ 231,733 Retained profit 2023: € 231,733 ▼ 61% vs 2022 (€ 596,366) Unfavourable step	€ 250,846 Retained profit 2024: € 250,846 ▲ 8% vs 2023 (€ 231,733) Favourable step	€ 307,938 Retained profit 2025: € 307,938 ▲ 23% vs 2024 (€ 250,846) Favourable step	▲ 23%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 590,000 Dividend 2023: € 590,000 Unchanged (€ 0) Unchanged	€ 220,000 Dividend 2024: € 220,000 ▼ 63% vs 2023 (€ 590,000) Unchanged	€ 200,000 Dividend 2025: € 200,000 ▼ 9% vs 2024 (€ 220,000) Unchanged	▼ 9%
Balance sheet total	€ 758,590 Balance sheet total 2022: € 758,590 First fiscal year in the series	€ 321,622 Balance sheet total 2023: € 321,622 ▼ 58% vs 2022 (€ 758,590) Unchanged	€ 261,245 Balance sheet total 2024: € 261,245 ▼ 19% vs 2023 (€ 321,622) Unchanged	€ 315,514 Balance sheet total 2025: € 315,514 ▲ 21% vs 2024 (€ 261,245) Unchanged	▲ 21%

Key figures of Dr. Le Clef Diagnostic Pathology, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Le Clef Diagnostic Pathology?

What happened at Dr. Le Clef Diagnostic Pathology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 27, 2026 New annual accounts for financial year 2025: profit of € 257,092 (▲ 8% vs 2024). Source: NBB ↗
Jul 10, 2020 New establishment in Antwerpen. KBO
Jul 10, 2020 Start of the company according to the CBE. KBO

In short

From € 267,746 profit in 2022 to € 257,092 profit in 2025.

Paid € 305,029 in corporate taxes since 2022.

Best year ever: 2022, with € 267,746 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Le Clef Diagnostic Pathology? We notify you, reason included.

Follow Dr. Le Clef Diagnostic Pathology

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Quentin Le Clef

Dr. Le Clef Diagnostic Pathology

Behind Dr. Le Clef Diagnostic Pathology is Quentin Le Clef.

See the full network in the app

Directors

According to the 2025 annual accounts

Quentin Le Clef

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Sanderusstraat 62

2018 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. Anneke van der Leden Pathologie

€ 236,162 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0750.547.792
VAT number: BE 0750.547.792
Registered office: Sanderusstraat 62, 2018 Antwerpen
Names & denominations: Dr. Le Clef Diagnostic Pathology
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 July 2020
Peppol: Active · Active since 21 Jun 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗